Update on the Role of Topotecan in the Treatment of Non-Small Cell Lung Cancer

Oncologist - United States
doi 10.1634/theoncologist.9-90006-43
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

On the Pharmacogenetics of Non-Small Cell Lung Cancer Treatment

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2016English

Bevacizumab in the Treatment of Non-Small-Cell Lung Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Innovations in the Treatment of Non-Small Cell Lung Cancer

English

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

The Increasing Role of Amphiregulin in Non-Small Cell Lung Cancer

Pathologie Biologie
2009English

Individualization of Treatment in Non-Small Cell Lung Cancer

F1000 Medicine Reports
2009English

Topotecan Monotherapy for the Treatment of Relapsed Small Cell Lung Cancer in Elderly Patients: A Retrospective Analysis

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2018English

Role of miR‑520b in Non‑small Cell Lung Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Unmet Needs in the Treatment of Metastatic Non-Small-Cell Lung Cancer

European Oncology and Haematology
OncologyHematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy